Highest-materiality recent filing
Lifeway Foods adds Jason Scher as director nominee for 2026 annual meeting, keeps board size at 8
Jason Scher reinstated as director nominee after board reversed earlier plan to shrink board from 8 to 7 directors.
Lifeway Foods prices secondary offering of 3.45M shares at $19.50; to repurchase $5M
Secondary offering of 3,454,756 shares by Danone USA at $19.50 per share; closing expected May 19, 2026.
Lifeway Q1 net sales $63.0M (+36.7% YoY); net income $4.7M, EPS $0.30
Record Q1 net sales of $63.0M, up 36.7% YoY, driven by volume-led growth in Lifeway Kefir and Farmer Cheese.
Lifeway Foods expects Q1 net sales $60.8-62.3M, up 32-35% YoY
Preliminary Q1 2026 net sales range $60.8M-$62.3M, 32-35% increase from Q1 2025.
Lifeway Foods reports record FY2025 net sales of $212.5M, up 13.7%; net income +54%
FY2025 net sales $212.5M (highest ever), up 13.7% YoY; 19% on comparable basis after strategic exit.
Lifeway Foods adopts standard deferred cash award forms under 2022 Omnibus Incentive Plan
Compensation Committee approved form notice for Deferred Time-Vested Cash Awards on March 6, 2026.
Lifeway Foods expects record 2025 net sales of $211M-$212.5M; to present at ICR Conference
Net sales for year ended Dec 31, 2025 expected in range $211M-$212.5M, a record for the company.
All 8 company-nominated directors elected; opposition nominees George Sent and Edward Smolyansky not elected.
Termination date extended to February 5, 2029; no outstanding borrowings at entry.
Lifeway Foods CEO presents at annual meeting; no material new disclosures
CEO Julie Smolyansky presented slides at the December 29, 2025 annual shareholder meeting.
Lifeway appoints two directors, attacks dissident nominees as unfit; annual meeting moved to Dec 29
Appointed Kirk Chartier and Susie Hultquist as directors effective Nov 26, 2025; annual meeting rescheduled from Dec 16 to Dec 29.
Lifeway Foods Q3 2025: Record net sales $57.1M, net income $3.5M, margin expands 300bps
Net sales $57.1M, up 24% YoY (29% on comparable basis); highest quarterly revenue in company history.
Lifeway Foods Director Perfecto Sanchez Resigns
Perfecto Sanchez resigned as director of Lifeway Foods on November 3, 2025.
Lifeway Foods appoints Andee Harris and Rachel Drori as directors; board size set at 8
Appointed Andee Harris and Rachel Drori to board effective October 29, 2025.
Lifeway extends shareholder rights plan to Oct 2026, citing concentrated ownership risk
Board approved Amendment No. 1 extending rights plan expiration to Close of Business October 29, 2026, from November 4, 2025.
Lifeway Foods sets Dec 16, 2025 annual meeting; shareholder proposals due Oct 20
Annual meeting scheduled for December 16, 2025.
Lifeway Foods pre-announces Q3 2025 net sales of $55.8M-$57.0M, up 21-24% YoY
Estimated Q3 net sales $55.8M-$57.0M, a 21-24% increase from Q3 2024.
Lifeway Foods director Jody Levy resigns effective October 1, 2025
Director Jody Levy notified the Board of her resignation on October 1, 2025.
Lifeway Foods signs Cooperation Agreement with Danone; adds independent directors, stays litigation
3 new independent directors appointed by Oct 30, 2025; 4th by Nov 14, 2025; Pol Sikar to step down at 2025 annual meeting.
Danone withdraws proposal to acquire Lifeway; Lifeway reports record Q2 sales
Danone has withdrawn its unsolicited acquisition proposal for Lifeway Foods (LWAY).
Lifeway pre-announces Q3-to-date net sales of $39.1M, up 20% YoY
Estimated unaudited net sales of $39.1M for July-August 2025, a 20% increase vs same period last year.
Lifeway Foods Q2 record net sales $53.9M, EPS $0.28; Q3-to-date sales up 20%
Q2 net sales $53.9M (record), up 9.7% YoY; 18% on comparable basis adjusting for exited customer.
ISS recommends Lifeway shareholders reject dissident consent solicitation
ISS recommends shareholders 'DO NOT VOTE' on all proposals in Ludmila & Edward Smolyansky-led consent solicitation.
Lifeway Foods reports record weekly gross sales of $5.5M, up 66% YoY
Gross sales for week ending July 13, 2025 surpassed $5.5M, a 66% increase from prior year.
Company says consent solicitation filed July 2 violates Illinois law and Lifeway's charter/bylaws.
Lump-sum cash payment of $555,313.13 less deductions, within 14 days of effective date.
Lifeway Foods provides Q2 guidance $52M-$56M; expands at major retailers
Q2 first two months net sales $37.6M, up 10.7% YoY; YTD net sales $83.7M as of May 31.
Lifeway Foods surpasses $5M weekly gross sales, up 35% YoY
Record weekly gross sales exceeded $5M for the week ending April 27, 2025.
Lifeway Foods responds to Edward Smolyansky's bid to replace entire board
Edward Smolyansky nominated seven candidates to replace Lifeway's entire Board at the 2025 annual meeting.
Lifeway Foods eliminates Senior EVP of Sales; Amy Feldman terminated without cause
Senior EVP of Sales position eliminated as part of organizational restructuring, effective Feb. 28, 2025.
Danone filed Schedule 13D referencing lawsuit; Lifeway calls it hostile takeover at undervalued price.
Lifeway Foods refutes Smolyansky family misstatements regarding CEO, board, share sale
Julie Smolyansky did not attend board vote on her retention bonus; independent directors voted only.
Lifeway expects $5M net profit from Simple Mills sale to Flowers Foods
Anticipates ~$5M net profit upon closing of Simple Mills sale; total expected proceeds ~$6.5M including prior $1.5M gain in 2019.
Lifeway Foods increases revolving credit facility from $5M to $25M, extends maturity to 2028
Revolving commitment raised from $5M to $25M with interest at Prime minus 1% or SOFR plus 1.75%.
Lifeway Foods expects 2024 net sales up ~16% YoY; reiterates rejection of Danone's $27/share bid
Preliminary Q4 2024 net sales $45.1M-$46.6M vs $42.1M in Q4 2023; full-year net sales $185M-$186.5M vs $160.1M in 2023.
Base salary set at $1,000,000 per year; target annual bonus 80% of base salary, target equity grant 75% of base salary.
Lifeway rejects Danone's $27/share revised proposal, citing substantial undervaluation
Board determined $27/share proposal substantially undervalues the company; not opposed to sale at any price.
Lifeway rejects Danone's revised $27.00/share proposal; declares 1999 stockholder agreement void
Lifeway's Board rejected Danone's revised unsolicited proposal to acquire all shares not already owned for $27.00/share, calling it substantially undervalued.
Lifeway Foods Rejects Danone's $27/Share Proposal; Calls Shareholder Agreement Void
Board unanimously rejects Danone's revised unsolicited proposal of $27.00 per share, saying it substantially undervalues the Company.
Lifeway Foods adopts poison pill, rejects Danone's $25/share buyout offer
Board rejected Danone's $25/share unsolicited proposal as substantially undervaluing Lifeway.
Lifeway Foods annual meeting: all directors elected, say-on-pay opposed by 41% of votes cast
Seven directors elected with strong support (lowest vote 10.3M for).
The elimination of this position constitutes a termination without cause, effective February 28, 2025, under Ms. Feldman’s Employment Agreement with the Company.
Max materiality 0.85 · Median 0.65 · Most common event other_material